Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA)

NANot yet recruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

November 1, 2027

Study Completion Date

November 1, 2030

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

Radio-induced Lymphocyte Apoptosis (RILA) Assay

peripheral blood sample processed via the RILA assay to quantify apoptotic CD8+/CD4+ T cells following ex vivo irradiation.

RADIATION

Stereotactic body radiotherapy (SBRT)

SBRT delivered to the prostate with image guidance, respecting dose constraints for organs at risk;

All Listed Sponsors
lead

Clinique Sainte Clotilde

OTHER